ABSTRACT. One postulated final common pathway lead-
subserially sectioned to 10 pM, and then stained with thionin/ acid fuchsin (26) . Each section was examined by light microscopy. The presence or absence of full thickness cerebral infarction was noted at low power ( 2 5~) , then each region was assessed under a magnification of 4 0 0~. Neurones with ischemic cell change as described by Brown and Brierley (27) , with acidophilic (red) cytoplasm and contracted nuclei or with just a thin rim of red cytoplasm with pyknotic nuclei were assessed as dead whereas all others were considered viable (26, 27) . Each region was scored for the proportion of dead neurones. The average value from four sections was used in all cases except for the lateral frontoparietal cortex where the average of four areas per section and four sections, spaced from anterior to posterior, were used. The damage scores were as follows: 0 = no dead neurones, 1 = >0-25%, 2 = >25-SO%, 3 = >50-75%, 4 = >75-100% of neurones were dead.
Data analysis. Damage and behavioral scores were analyzed by two-way analysis of variance for litter and treatment group. t tests were performed to test differences between subgroups. Survival, the incidence of behavioral problems and of cerebral infarction were examined by X 2 test, except when the numbers were low, where Fishers exact test was used. All values are expressed as mean + SD.
RESULTS
Pilot Study. Behavioral testing. No sham controls (n = 23) or flunarizine rats (n = 5) had acute behavioral changes whereas eight of nine true controls (subject to hypoxia and ligation) showed significant abnormalities ( p < 0.01). A consistent pattern was seen of acute disturbances that were worse in the 24 h after the insult and gradually resolving over 2 to 3 days with only mild unilateral weakness still apparent by 10 days.
Histology. Hemispheric size was symmetrical in all flunarizinetreated (n = 4) and sham rats (n = 20) but in six of eight control rats the hemisphere on the ligated sided was smaller ( p < 0.05).
The density of intact neurons in the corpus striatum was markedly reduced on the ligated side vs the nonligated side (1.34 + 0.76 vs 2.29 + 0.9 1, x lo8 neurons/M2) in the controls (n = 8, p < 0.005) but not in the flunarizine treated animals (n = 4, NS), Main Study. A total of 77.5% of controls (n = 40) and 84% of flunarizine (n = 32) pretreated rats survived (NS). The majority of those who died did so during the hypoxia, and there were no deaths more than 12 h after cessation of the hypoxia.
Behavioral testing. The same pattern of acute and residual abnormalities was seen as in the pilot study. Acute problems included both generalized fits and focal motor convulsions with secondary generalization. The righting response was frequently absent or greatly slowed, although many circled repeatedly in one direction, usually away from the side of ligation although a few had an increased tendency to turn in that direction. Only one (control) animal showed an abnormal startle response and all responded-to a tail pinch. Acute motor problems were less frequent ( p < 0.002) in flunarizine pretreated animals (1 I%, n = 27) than in control animals (5 1.6%, n = 31). These resolved progressively and persisted at 5 days in only one control rat. As is shown in Figure 1 the mean duration of each of the three motor problems: fitting, abnormal circling, and impaired righting, was reduced in the flunarizine rats ( p < 0.005).
Once the acute disturbance had resolved, residual deficits were more frequent in controls than flunarizine-treated animals. A total of 42% of controls vs 4% of flunarizine rats showed a unilateral palsy contralateral to the ligation ( p < 0.001); other problems were infrequent. The acute and residual scores were highly intercorrelated (? = 0.69, p < 0.00001).
Histology. Cerebral injury ranged from no damage, to laminar loss in layer 3 of the lateral cortex or selective loss in the CA1/2 region of the hippocampus, through to gross infarction. Only 4% (n = 27) controls vs 29% (n = 24) flunarizine animals had absolutely no dead neurons in any section examined ( p < 0.02).
When rats with less than 5% neuronal death in at most two regions were considered with the normals as having trivial damage the difference is striking: 11 % of controls vs 58% of flunarizine rats ( p < 0.001) had trivial damage.
Full thickness infarction of the cerebral cortex was much more frequent in controls (55.5%) than in flunarizine pretreated rats (4%, p < 0.001). The mean damage scores were significantly less in the flunarizine-pretreated pups in every region examined (Fig.  2) , with the reduction in damage varying by >80% in the cortex ( p < 0.0001) and by >50% in the CA1/2 region of the hippocampus ( p < 0.006). The lesser degree of improvement in hippocampal scores compared with cortex or striatum was significant ( p < 0.0 1). Although ischemic damage was documented
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Cummulative Reflex Score primarily ipsilateral to the ligation, eight rats had minor (grade 1 or 2) damage on the unligated side: 26% of controls vs 4% flunarizine rats ( p < 0.05). Of these, the majority (6/8) had CAI/ 2 lesions.
DISCUSSION
Flunarizine, a difluorinated piperazine derivative, is a calcium channel antagonist binding to the dihydropyridine binding site (28) . It crosses the blood brain barrier and is relatively selective for the cerebral circulation, having little effect on the heart or systemic vasculature (29) . In the present study pretreatment with flunarizine was associated with a dramatic reduction in histologic damage. The acute and chronic behavioral abnormalities were significantly improved.
Two other studies have examined effects of calcium antagonists in immature animals. In 7-d-old rats, subject to the Levine model, 30 mg/kg of flunarizine limited morphologic injury (20). Our study confirms and extends this result with behavioral measures and more detailed histologic assessment. Improved short term (2 h) improvement in evoked potentials was found after 10-1 5 min of cardiac arrest in newborn sheep using 3 mg lidoflazine (21) . Unfortunately that study is confounded by the use of multiple other agents including free radical antagonists, short follow-up, and the absence of histologic data.
A range of studies in mature animals suggests that flunarizine is as or more effective than other calcium antagonists in preventing asphyxia1 damage. Flunarizine but not verapamil is effective in preventing death due to cyanide induced cellular hypoxia in rats (7). Recovery was improved in mice and rats by its administration prehypoxia/anoxia (8) and pre-(9) but not post-(10) cardiac arrest in the dog. In the adult Levine rat, pretreatment with 10-40 mg/kg of flunarizine reduced parietal neuronal damage (I I), whereas only the maximum dose of nicardipine was minimally protective and diltiazem was not (12) . In a rat model of partial ischemia, both pre-and postinsult treatment markedly improved histologic outcome in the hippocampus (l4), striatum, and cortex (15) . In the dog after cardiac arrest, 0.1 mg/kg intravenously reduced neuronal death only in the hippocampus suggesting that higher doses may be needed for cortical protection (I 6).
The most direct explanation for the overall neuroprotective action of flunarizine is inhibition of calcium uptake by neurones. Both enhanced excitatory neurotransmitter activity and depolarization due to energy failure favor excessive calcium entry, which in turn may activate a series of damaging events such as protein and phospholipid degeneration and release of ecosanoids and kinins, leading to delayed neuronal death (3, 4) . Calcium ionophores, by promoting calcium entry produce neuronal death (30) , whereas calcium free media are protective (4). Flunarizine inhibits depolarization induced uptake of Ca" into rat synaptosomes in vitro (3 I) and delays the fall in extracellular Ca+' in the hypoxic rat brain (32) .
The overall histopathologic pattern of damage in the controls corresponds with the tenitory of the middle cerebral artery (33): damage appears to be localized primarily by a preferential fall in middle cerebral artery perfusion on the ligated side during hyuoxia (24. 34). In the infant Levine rat blood flow is dramaticallv sant (39) . Seizures may aggravate cerebral damage induced by asphyxia (40, 41) . The effective anticonvulsant dose in rats is similar to that used in this study where the flunarizine-treated rats had significantly less posthypoxic fitting than the controls.
The behavioral changes seen here of transient abnormal turning, impaired righting, fits and residual hemiparesis, are similar to those documented in adult rats (25, 27) . In contrast in 7-dold rats subjected to the Levine model, only trivial behavioral abnormalities can be identified (23, 42), most likely due to the rapid resolution of acute behavioral disturbances and the delay before the acquisition of motor skills.
The perinatal period is one situation where it is possible to predict likely episodes of asphyxia. Thus antepartum prophylaxis using calcium channel antagonists may be a potential therapeutic approach (43) . However, considerable experimental investigation of the safety of such an approach will be required before therapeutic trials are considered.
